Pancreatic cancer
Conditions
Interventions
Intervention group Communication support for physicians: Using the communication skills training (SHARE-CST) text book and DVD, lecture about the communication desired by the patient, how to use the
Sponsors
National Cancer Center
National Cancer Center Hospital East The Cancer Institute Hospital of JFCR Kanagawa Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient 1) Disease (cancer site) Patient is diagnosed as pancreatic cancer (adenocarcinoma) 2) Extent of disease Patients with unresectable pancreatic cancer (UICC stage III or IV) or patients that started their primary chemotherapy for postoperative reccurence and are scheduled with second course chemotherapy. 3) Age Ages above 20 4)PS:Performance status ECOG performance status score:0-1 5) Written informed consent for participating in the study is obtained from the patient 6) Receive periodic anticancer drug treatment from the physician participating in this study. 7) Understands Japanese. Caregiver 1) Age Ages above 20 2) Person who will accompany the patient participating in this study, on the day of the intervention, and the recording day (which is the main evaluation of this study). 3) Written informed consent for participating in the study is obtained from the patient's caregiver. 4) Understands Japanese Physician 1) The physician who is mainly engaged in the anticancer drug treatment of the pancreatic cancer patient whom will participate in this study. 2) Written informed consent for participating in the study is obtained from the physician.
Exclusion criteria
Exclusion criteria: Patients/companions who fall under any of the following are excluded. Do not set exclusion criteria for physicians. 1) Degradation of severe cognitive function due to delirium, dementia, etc. is recognized. 2) It is difficult to operate the touch panel. 3) In addition, it is judged unsuitable for practicing this exam by physicians.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is the difference between the group of the difference before and after the average value of the average value of the doctor's SHARE impression rating to be evaluated at the outpatient examination (the third week of the first chemotherapy 2) before and after the communication intervention (after opening the control group for about one week) is there. | — |
Secondary
| Measure | Time frame |
|---|---|
| For doctor / patient behavior, evaluate using RIAS at outpatient examination after communication intervention (control group is emptied about one week). In addition, the following items are evaluated at each stage of 3, 6, 12, 24, and 36 months after the outpatient examination at registration, after communication intervention (after opening the control group for about one week). During the hospital visit during the hospital visit during the visit, postmortem at the post. Patient 1) Psychological stress of the patient 2) patient's QOL 3) Trust in doctors 4) Satisfaction with examination 5) Acceptance of cancer in patients 6) Relevance of intervention method: completion rate, intervention time, usefulness, satisfaction, burden feeling 7) Recognition of patient's healing 8) Medical use: Anticancer treatment after standard treatment, treatment with invasion, emergency delivery, ward hospitalization, out-of-ward examination, telephone consultation, hospice ward use, home medical examination visit, survival period Caregiver 1) QOL of caregiver 2) Psychological stress of caregivers 3) Satisfaction to the examination 4) Recognition of patient's healing 5) Relevance of intervention method: completion rate, usefulness, satisfaction, burden feeling Doctor 1) Relevance of the intervention method: completion rate, usefulness, satisfaction, burden feeling | — |
Countries
Japan
Contacts
Public ContactMaiko Fujimori
National Cancer Center Institute for Cancer Control Division of Supportive Care, Survivorship and Translational Research
Outcome results
None listed